SEC
SlamSEC
SearchBrowseEarnings

Immuron Ltd

Nasdaq:IMRN
Pharmaceutical Preparations·CARLTON, VICTORIA, C3
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.